Liang et al. (154) found the trifucosylated N-glycan of AGP presented in HCC patients but absent in healthy controls and most cirrhosis patients and could differentiate HCC from cirrhosis with AUROCs of 0.707–0.751 in various causes of liver diseases and exhibited an AUROC of 0.709, sensitivity of 52%, and specificity of 80% for differentiating ANHC from LC. The gene discussed is ATP5MK; the disease is hepatocellular carcinoma.